Alternative to Alimta Coming for Mesothelioma Patients
The U.S. Food and Drug Administration has granted final approval of Pemfexy, a new brand of the chemotherapy drug pemetrexed, to combat malignant mesothelioma and advanced stage non-small cell lung cancer. The approval will allow oncologists to offer an alternative to Alimta, which today is considered standard pemetrexed and manufactured by Eli Lilly and Company. The chemotherapy drug is designed to block DNA replication and cell division. However, Pemfexy will not be available until February 2022. The FDA approval is limited to pleural mesothelioma patients whose disease is unresectable. Pemfexy is produced by Eagle Pharm...
Source: Asbestos and Mesothelioma News - February 12, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

FDA Moves Closer to Standardized Testing for Asbestos in Talc
The U.S. Food and Drug Administration moved closer on Tuesday to formulating standardized testing of talc-based products for the presence of toxic asbestos fibers. Experts from eight different federal agencies explained earlier recommendations at a day-long hearing. The session also featured input from 25 members of the public, which included industry representatives, consumer advocates and testing experts. “Standards are needed,” said Dr. Paul Howard, FDA Office of Regulatory Science, during his presentation. “They just don’t exist at this time.” Dr. Linda Katz, director of the FDA Office of ...
Source: Asbestos and Mesothelioma News - February 5, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Duke Completes Largest Study of Mesothelioma in Women
This study of women included 275 cases of pleural mesothelioma and 79 cases of peritoneal. Papillary mesothelioma and localized mesothelioma cases were excluded. Previous reports have shown that 22% to 29% of mesothelioma cases involve women, but only 12% in this particular study. Other Notable Takeaways The majority of those studied were exposed to asbestos through household contact. Women who worked in occupations and industries associated with higher asbestos exposure had objective markers of exposure similar to men. Survival was longer for the epithelial subtype of mesothelioma and magnified with the per...
Source: Asbestos and Mesothelioma News - February 5, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Deaths Peak 30 Years After Asbestos Ban
Almost 30 years after Italy passed sweeping legislation that banned the mining, use and commercialization of asbestos, the country is facing the peak of its mesothelioma cancer crisis. The worst has just arrived. Asbestos may be the primary cause of mesothelioma, but banning it did not slow the rate of diagnosis or death from this rare and aggressive cancer. The International Journal of Environmental Research and Public Health published an in-depth study recently that examined the connection in Italy between its ban of asbestos and the deaths from mesothelioma. Researchers found there is no immediate benefit from an asbest...
Source: Asbestos and Mesothelioma News - January 30, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

ONCOS-102 Shows Promise in Combination Mesothelioma Treatment
ONCOS-102, a promising immunotherapy vaccine, is moving closer to becoming a part of future first-line treatment for mesothelioma. Early clinical trial results announced this week show safety and efficacy when the vaccine is used in combination with standard-of-care chemotherapy for patients with inoperable pleural mesothelioma. Targovax, a Scandinavian pharmaceutical company developing the drug, is moving forward with another study combining ONCOS-102 with a checkpoint inhibitor drug such as Keytruda (pembrolizumab) or Opdivo (nivolumab), along with chemotherapy. “We have seen enough data at this point to be going ...
Source: Asbestos and Mesothelioma News - January 27, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

FDA Panel Recommends Standardized Talc Testing for Asbestos
A team of experts from eight different federal agencies has presented the U.S. Food and Drug Administration with preliminary recommendations to standardize the testing of talc for the presence of asbestos and other potentially harmful mineral products. The recommendations, some of which reject long-held talc industry positions, are designed to end the discrepancies in analysis of whether talc products are contaminated with cancer-causing substances. Preliminary recommendations will be part of the FDA’s public meeting on Feb. 4 to discuss and obtain scientific information on testing for asbestos in talc-based products...
Source: Asbestos and Mesothelioma News - January 21, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Study Uncovers Drug Combination for Sarcomatoid Mesothelioma
Researchers in Spain have discovered a drug combination showing potential in treating the most difficult-to-treat type of malignant mesothelioma. Selumetinib and AZD8186, already being studied separately in clinical trials for other cancers, displayed efficacy when used in combination on mesothelioma of the sarcomatoid cell type. Researchers at the Spanish National Cancer Research Centre made the discovery during their study using mice models and human tumor cells in the laboratory. “The findings, we hope, are relevant,” Dr. Paco Real, who led the study, told The Mesothelioma Center at Asbestos.com. “We d...
Source: Asbestos and Mesothelioma News - January 16, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Researchers Find Potential New Target for Mesothelioma Treatment
An international research team has identified a novel molecular target with potential to significantly improve future treatment of malignant pleural mesothelioma. The recent findings could lead to a drug that targets key genetic inhibitors often preventing a patient’s own immune system from suppressing mesothelioma tumor growth. Dr. Antonio Giordano, part of the collaborative research team, said the goal is reducing mesothelioma mortality with a combinational therapy that includes this new target. “These findings help us define molecular mechanisms that may be key to mesothelioma aggressiveness and progression,...
Source: Asbestos and Mesothelioma News - January 14, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Pleural and Peritoneal Mesothelioma Combination Can Be Managed
A patient diagnosed with pleural and peritoneal mesothelioma today can survive well beyond expectations, provided personalized treatment can be found at a specialty center. Research from the Columbia University Medical Center in New York City has shown that despite the poor prognosis typically accompanies this rare diagnosis, patients still can thrive. “This is an understudied, and poorly understood, group of patients that often is just written off,” surgical oncologist Dr. Michael Kluger at Columbia told The Mesothelioma Center at Asbestos.com. “But we’ve shown a meaningful survival.” Kluger,...
Source: Asbestos and Mesothelioma News - January 9, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice
(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) Currently, there are few effective treatments for malignant mesothelioma, although it has been decades since it was found that the major risk factor is exposure to asbestos. The drugs identified by CNIO researchers are being tested on other types of cancer, which can speed up clinical trials for mesothelioma. The authors identified molecular markers that could be used to determine which patients could benefit most from this new therapy, provided that it is approved. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 8, 2020 Category: Cancer & Oncology Source Type: news

Study: No Major Link Between Baby Powder, Cancer
The use of talc powder has been linked to other types of cancer, such as mesothelioma. A jury recently awarded a California couple nearly $30 million from Johnson & Johnson for the wife's mesothelioma, according to a CNN report. (Source: WebMD Health)
Source: WebMD Health - January 7, 2020 Category: Consumer Health News Source Type: news

US Officials Respond to Asbestos Issue at Tokyo 2020 Water Polo Venue
Officials with USA Water Polo are confident that organizers of the 2020 Tokyo Summer Olympics will fix an ongoing asbestos issue at the water polo venue for this year’s games. Japanese newspaper The Asahi Shimbun originally reported that officials had discovered asbestos-containing insulation in at least two locations of the Tatsumi International Swimming Center in 2017. But the human carcinogen was not removed during renovations to the arena. Exposure to asbestos is the primary cause of mesothelioma, a deadly cancer with no definitive cure. Following reports of the asbestos issue, Tokyo 2020 organizers are taking...
Source: Asbestos and Mesothelioma News - January 6, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Genetic Research Team Receives $2.6M Grant from NIH
Dr. Michele Carbone at the University of Hawaii Cancer Center has good reason to start 2020 optimistic about advancing the treatment of malignant pleural mesothelioma. The National Institutes of Health awarded his research team a five-year, $2.6 million grant last month to continue its work linking the BAP1 gene mutation to the development of mesothelioma cancer. It may hold the key to an eventual cure. “This [grant] moves us in the right direction. There is reason to be hopeful,” Carbone told The Mesothelioma Center at Asbestos.com. “There is one thing left to do, develop the resources to cure this horri...
Source: Asbestos and Mesothelioma News - January 2, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Study: Mesothelioma Patients with CD70 Protein Have Worse Prognosis
An international team of pathologists has identified a new protein often found on pleural mesothelioma tumor cells. The discovery could lead to a more accurate prognosis for patients and future treatment advances. Researchers found for the first time that mesothelioma patients expressing higher levels of the CD70 protein typically experience a much shorter survival, regardless of cell type or treatment type. “These markers might be useful for MPM [malignant pleural mesothelioma] prognostic evaluations, as well as targeted therapeutics,” the study authors wrote. “Further analyses in syngeneic mouse models...
Source: Asbestos and Mesothelioma News - December 19, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Canadian Town of Asbestos Changing Its Name for Economics
Officials in Asbestos, Quebec, have been struggling for years to develop a new identity for the small Canadian mining town. Changing its name might do the trick. Mayor Hugues Grimard announced recently that his town in southeastern Quebec is looking for a name change in 2020, believing it could spark a much-needed economic recovery. The natural link between the town’s name and the toxic mineral — once so compelling — has become a roadblock to any future development. Exposure to asbestos can lead to deadly diseases, including mesothelioma cancer. “There is really a negative perception around asbestos...
Source: Asbestos and Mesothelioma News - December 9, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Comparative Study Reveals Best Mesothelioma Surgery
Less is usually better than more when it comes to aggressive surgery for pleural mesothelioma, according to the latest and most-extensive comparative study. Throughout the last 25 years, surgical patients typically fared better with the lung-sparing pleurectomy and decortication (P/D) than with the more radical extrapleural pneumonectomy (EPP). “We found that the P/D approach should be preferred when technically feasible,” Dr. Dimitrios Magouliotis of the General University Hospital of Larissa in Greece, told The Mesothelioma Center at Asbestos.com. “We believe now the P/D should be the first choice.&rdqu...
Source: Asbestos and Mesothelioma News - December 5, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

DaSilva Building Mesothelioma Specialty Program in Orlando
Thoracic surgeon Dr. Marcelo DaSilva came to Orlando, Florida, with a lofty goal. He wants to make Central Florida a destination for patients diagnosed with malignant pleural mesothelioma. DaSilva also has the tools to make that goal a reality, building a mesothelioma specialty program at AdventHealth Orlando. “We want to make this a nationally — and internationally — recognized program,” DaSilva told The Mesothelioma Center at Asbestos.com. “People who come to Orlando will not only see Disney World, but they will see excellence in health care. We can do that here.” DaSilva was named chi...
Source: Asbestos and Mesothelioma News - December 3, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Report: 1.5 Million UK Buildings Contain Asbestos [Infographic]
Asbestos may have been banned in the United Kingdom 20 years ago, but the deadly carcinogen continues to be the leading cause of occupational death, leading to 5,500 deaths in the U.K. last year. According to a new report by ResPublica, an estimated six million tons of the deadly carcinogen remain inside 1.5 million buildings in the U.K., including schools and hospitals — many of which were built prior to the 1999 ban. Exposure to asbestos is directly connected to multiple diseases, including mesothelioma, lung cancer and asbestosis. Jump to the full infographic: Asbestos Risk in UK Hospital...
Source: Asbestos and Mesothelioma News - November 27, 2019 Category: Environmental Health Authors: Daniel King Source Type: news

Latest Mesothelioma Clinical Trial Opens at Memorial Sloan Kettering
Memorial Sloan Kettering Cancer Center in New York City has opened its latest clinical trial for patients with pleural mesothelioma, studying the effectiveness of an immunotherapy and chemotherapy combination prior to aggressive surgery. The novel feasibility study will determine if the use of Opdivo (nivolumab) with Alimta (pemetrexed) and either cisplatin or carboplatin — without delaying scheduled surgery — can significantly extend patient survival time. The hope is to duplicate earlier effectiveness of that same combination with other cancers. “It has been tried with promising results,” Memorial...
Source: Asbestos and Mesothelioma News - November 27, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Secretome of pleural effusions associated with non-small cell lung cancer (NSCLC) and malignant...
(Impact Journals LLC) Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system. Comparing NSCLC PE and published plasma levels of CAR-T recipients, both were dominated by sIL-6R and IL-6 but NSCLC PE had more VEGF, FGF2 and TNF, and less IL-2, IL-4, IL-13, IL-15, MIP1 and IFN. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 22, 2019 Category: International Medicine & Public Health Source Type: news

Teacher diagnosed with mesothelioma to sue school district she claims exposed her to asbestos 
Lea DiRusso, 51, of South Philadelphia, Pennsylvania, was diagnosed with mesothelioma, a cancer of the tissue that lines the organs that she blames on asbestos-filled schools. (Source: the Mail online | Health)
Source: the Mail online | Health - November 21, 2019 Category: Consumer Health News Source Type: news

Celebrities Paint Masks for Mesothelioma Fundraising Event
The goal of the Pacific Mesothelioma Center is to be the most innovative nonprofit research and cancer treatment organization in the world. Its latest fundraising event is a perfect example. As part of the Pacific Heart, Lung & Blood Institute, the Pacific Mesothelioma Center will play a major role in the unMASKing the Cure for Cancer Gala, an innovative fundraising idea once used by Prince Charles more than 20 years ago. The November 21 event, held at the UCLA Luskin Conference Center, includes the auctioning of eclectic masks that were hand-painted by various celebrities, including actors, artists, athletes and music...
Source: Asbestos and Mesothelioma News - November 19, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Johnson & Johnson Rushed Tests of Asbestos in Baby Powder
A new report reveals Johnson & Johnson rushed the test results of its iconic baby powder to show it was free of asbestos contamination. The Wall Street Journal reported Sunday that two independent laboratories found no evidence of asbestos in the same recalled lot of baby powder used in the U.S Food and Drug Administration report last month. But evidence shows the quick turnaround on the tests may have impacted results. One of those laboratories, commissioned by J&J after the FDA report, initially found asbestos in the talc sample, but quickly recanted. It told J&J the sample had been contaminated by the air...
Source: Asbestos and Mesothelioma News - November 18, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Death from 9/11 Signals Start of Things to Come
Malignant mesothelioma has become the latest deadly cancer linked directly to the rescue, recovery and cleanup efforts following the 9/11 terrorist attack on New York City in 2001. The long-running threat has come to fruition. Eighteen years after Manhattan was engulfed in the asbestos-laced, toxic cloud of dust — caused primarily by the World Trade Center destruction — the first death from pleural mesothelioma attributed to 9/11 has been recorded. Nick Ursta, 52, from the southwestern part of Pennsylvania, died after a year-long battle with the rare cancer. Ursta, a construction worker and fireman by trade, w...
Source: Asbestos and Mesothelioma News - November 14, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

EPA Leaving Libby Asbestos Superfund Site to Montana
The U.S. Environmental Protection Agency is leaving the Libby Asbestos Superfund site, but that doesn’t mean the job is finished. It’s just changing hands. The Montana Department of Environmental Quality will assume the oversight role of the Superfund site, which was part of the longest-running, man-made environmental disaster in American history. The EPA spent almost two decades decontaminating Libby and nearby Troy, Montana, a massive project stemming from the vermiculite mine operation that once spread asbestos dust throughout the region, sickening both miners and residents throughout Lincoln County. More th...
Source: Asbestos and Mesothelioma News - November 11, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Miami Cancer Institute Begins Using Novel Treatment for Mesothelioma
The Miami Cancer Institute on Thursday will begin using the innovative Tumor Treating Fields device for patients with malignant pleural mesothelioma. It is the first new treatment approved for mesothelioma by the U.S. Food and Drug Administration in more than 15 years. “This is actually pretty exciting for us,” Dr. Rupesh Kotecha, the radiation oncologist who will oversee the treatment protocol in Miami, told The Mesothelioma Center at Asbestos.com. “It’s another tool in our armamentarium. It’s something we can offer patients that has shown a real benefit.” The noninvasive Tumor Treating...
Source: Asbestos and Mesothelioma News - November 6, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Major Retailers Pull J & J Baby Powder After FDA Finds Asbestos
Major retailers have stopped selling the 22-ounce bottles of Johnson & Johnson baby powder after last week’s announcement that the U.S. Food and Drug Administration found traces of asbestos in one of the containers. Exposure to asbestos, a naturally occurring mineral and known carcinogen, is the primary cause of malignant mesothelioma, a rare and aggressive cancer with no definitive cure. Walmart, CVS Pharmacy and Rite Aid were among the many retailers that have pulled the product from shelves as part of the voluntary recall. “We always put customer safety first and foremost,” Chris Savarese, Rite Aid...
Source: Asbestos and Mesothelioma News - October 25, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Tumor Treating Fields Showing Early Success for Mesothelioma
Dr. Giovanni Ceresoli doesn’t think Tumor Treating Fields will work for every patient with mesothelioma cancer, but he knows it will work for some. They are in his clinic. As the principal investigator of the multicenter clinical trial that led to approval by the U.S. Food and Drug Administration in May, Ceresoli has played a major role in the development of this latest mesothelioma treatment. “It might be too early to say this is a major breakthrough — we need more data — but I hope it is. I know it’s something promising, very promising,” Cerosoli told The Mesothelioma Center at Asbest...
Source: Asbestos and Mesothelioma News - October 23, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Study Links Asbestos in Talcum Powder to Deadly Cancer
MONDAY, Oct. 21, 2019 -- As concerns about baby powder being contaminated with asbestos mount, a new study finds a link between such contamination and a rare and deadly cancer. A group of 33 people developed mesothelioma after long-term use of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 21, 2019 Category: General Medicine Source Type: news

High pollution days send hundreds to hospital
Sudden pollution spikes trigger heart attacks, asthma and strokes Related items fromOnMedica Brexit could result in thousands of extra CVD deaths Cars should be banned from around schools Taxing sugary foods would cut prevalence of obesity Public health chiefs set out NHS plan targets Mesothelioma deaths reach their peak (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 21, 2019 Category: UK Health Source Type: news

Johnson & Johnson Recalls Batch of a Baby Powder After Trace Asbestos Found in Bottle
Johnson & Johnson on Friday recalled a single batch of its baby powder as a precaution after government testing found trace amounts of asbestos in one bottle bought online. The recalled lot consists of 33,000 bottles which were distributed last year. J&J said the U.S. Food and Drug Administration found minuscule amounts of asbestos in one bottle during routine testing and notified the company on Thursday. J&J said it immediately began investigating with the FDA. “The FDA’s testing on prior occasions, and as recently as last month, found no asbestos,” said spokesman Ernie Knewitz. J&J said ...
Source: TIME: Health - October 18, 2019 Category: Consumer Health News Authors: LINDA A. JOHNSON / AP Tags: Uncategorized onetime public health Source Type: news

J & J Recalls Baby Powder After FDA Finds Asbestos
Johnson & Johnson announced a voluntary recall on Friday of an estimated 33,000 bottles of its iconic baby powder after the U.S. Food and Drug Administration found traces of asbestos in a bottle purchased recently from an online retailer. The company also said that it was working closely with federal authorities to determine the validity of the test results and the integrity of the tested sample. FDA testing indicated sub-trace levels of chrysotile asbestos contamination, defined as no greater than 0.00002%, according to the announcement. Exposure to asbestos, a naturally occurring mineral and known carcinogen, is the ...
Source: Asbestos and Mesothelioma News - October 18, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

J&J recalls Baby Powder after FDA finds cancer-causing asbestos in a bottle
Food and Drug Administration tests found 'sub-trace' amounts of asbestos, a contaminant linked to cancer in a bottle of Baby Powder. J&J faces 13,000 lawsuits over mesothelioma from talc. (Source: the Mail online | Health)
Source: the Mail online | Health - October 18, 2019 Category: Consumer Health News Source Type: news

Case Study Shows Asbestos in Talc Causes Mesothelioma
This study was the first large case series to identify contaminated cosmetic talc as the cause of mesothelioma and the first to use background controls dictated by no known asbestos exposure. It emphasizes the continued risk from common cosmetic products once thought to be safe for all. “I would tell people that there is no regulation for talc, and that if there is a safer alternative, than I would advise them to do that,” Moline said. “I would not recommend people use talcum powder.” The post Case Study Shows Asbestos in Talc Causes Mesothelioma appeared first on Mesothelioma Center - Vital Service...
Source: Asbestos and Mesothelioma News - October 18, 2019 Category: Environmental Health Authors: Daniel King Source Type: news

Effective Second-Line Treatment for Mesothelioma Gaining Ground
Doctors at the Swiss Group for Clinical Cancer Research in Zurich, Switzerland, have uncovered a novel, anti-tumor compound that could become a needed second-line treatment for pleural mesothelioma cancer. Their recent multicenter phase II clinical trial conducted in Switzerland and Italy revealed the safety and efficacy of lurbinectedin, a synthetically produced agent that inhibits the growth of mesothelioma cells. “We believe this could represent a new treatment option for pleural mesothelioma,” Dr. Yannis Metaxas, oncologist at Kantonsspital Graubunden outside Zurich, told The Mesothelioma Center at Asbestos...
Source: Asbestos and Mesothelioma News - October 17, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

A New Study Suggests Tainted Talcum Powder Can Cause a Rare Cancer. Here ’s How That Could Play Out in the Courtroom
A new 33-patient case study published in the Journal of Occupational and Environmental Medicine provides some of the strongest proof yet that exposure to asbestos-tainted talcum powder may cause malignant mesothelioma, a rare and deadly cancer that affects tissues lining internal organs. This isn’t only an important scientific discovery—it could also give new ammunition to plaintiffs in the thousands of cases brought against brands selling talcum-powder-based products alleged to cause cancer, like Johnson & Johnson’s Baby Powder. “It’s very, very hard, in general, to prove exactly what cau...
Source: TIME: Health - October 15, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Environmental Health HealthSummit19 Research toxins Source Type: news

New York ’s MTA Ignored Asbestos Dangers for Years
Glaring safety issues involving asbestos exposure within the Metropolitan Transportation Authority extend further than the East New York bus depot in Brooklyn, a report from the agency’s inspector general alleges. Inhaling or ingesting tiny asbestos fibers in the air can lead to serious health conditions later in life, including mesothelioma cancer. The inspector general report, released Monday, shows MTA managers ignored asbestos safety concerns at bus and train facilities across New York City for years. Asbestos-containing materials were found in disrepair in the boiler rooms of at least six MTA depots throughout...
Source: Asbestos and Mesothelioma News - October 8, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Keytruda for Mesothelioma Flops in Phase III Clinical Trial
Results from a phase III clinical trial comparing Keytruda (pembrolizumab) to standard chemotherapy shows the immunotherapy drug still has a long way to go as a viable treatment option for malignant pleural mesothelioma. Keytruda did not improve progression-free survival for mesothelioma patients who progressed after first-line chemotherapy. The disappointing results from the PROMISE-meso study were presented at the European Society of Medical Oncology (ESMO) annual meeting last week. It was the first randomized trial comparing progression-free survival between immunotherapy and first-line chemotherapy for mesothelioma p...
Source: Asbestos and Mesothelioma News - October 7, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Idaho woman wins $40 million in lawsuit over baby powder-linked cancer
A California jury has awarded Nancy Cabibi, 71, over $40 million after alleging she developed mesothelioma from using Johnson & Johnson's baby powder, which contains the carcinogen, asbestos. (Source: the Mail online | Health)
Source: the Mail online | Health - October 1, 2019 Category: Consumer Health News Source Type: news

First Mesothelioma Patient Begins Newly Approved Treatment
A mesothelioma patient at West Cancer Center in Memphis, Tennessee, is the first in the country to use NovoTTF-100L, a noninvasive electric therapy treatment, since its approval by the U.S. Food and Drug Administration in May. The FDA’s approval of Novocure’s Tumor Treating Fields device for the treatment of mesothelioma marked the first new FDA-approved treatment option for the rare asbestos-related cancer in more than 15 years. NovoTTF-100L uses a low-voltage electrical field that is distributed with three pads attached to the front and back of a person’s chest. The electrical current is designed to di...
Source: Asbestos and Mesothelioma News - October 1, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Disappointment Over Immunotherapy in Mesothelioma Disappointment Over Immunotherapy in Mesothelioma
Despite achieving better response rates in the second-line treatment of malignant pleural mesothelioma, pembrolizumab did not improve survival over chemotherapy in a phase 3 trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 30, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Inspector General Report: Asbestos Exposure a Concern on Army Posts
Residents in privatized housing on nearly 50 Army installations cited concerns with issues such as lead paint and asbestos, the toxic building material linked to mesothelioma cancer, according to a recent report from the Department of the Army Inspector General. The report, which was made public earlier this month, includes surveys, document reviews and interviews with residents at 49 Army installations across the U.S., including Fort Bragg (N.C.), Fort Campbell (Ky.) and Fort Hood in Texas. Military families at 48 of the 49 sites cited concerns with safety or environmental issues inside the aging on-base housing at the ...
Source: Asbestos and Mesothelioma News - September 25, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

How Slow Moving Asbestos Regulations Compromise Health
By Sarah WolvertonWALLINGFORD, CT, US, Sep 24 2019 (IPS) Last year, the United States introduced a new asbestos rule that was received both positively and negatively and Canada banned the mineral altogether. Countries like the U.K. and Australia continue to struggle with the health implications of historic asbestos use, despite both having bans for several years. In contrast, nations like Russia and Vietnam continue to manufacture and use the mineral frequently.  Asbestos is a substance that was used throughout history as an additive in many products to provide heat and fire resistance. It fell out of favor around the...
Source: IPS Inter Press Service - Health - September 24, 2019 Category: International Medicine & Public Health Authors: Sarah Wolverton Tags: Development & Aid Environment Headlines Health Source Type: news

Medicare Now Covers CAR T-Cell Therapy for Approved Cancers
A promising and expensive type of immunotherapy, called CAR T-cell therapy, is now covered by Medicare. This news may affect mesothelioma patients in the future. Chimeric antigen receptor T-cell, or CAR T-cell, therapy involves the laboratory reprogramming of a patient’s T cells, which are a type of white blood cell responsible for protecting the body against infection and disease. The T cells are genetically modified to better recognize and attack cancer. The U.S. Food and Drug Administration has approved the immunotherapy procedure for non-Hodgkin lymphoma and B-cell precursor acute lymphoblastic leukemia. It is...
Source: Asbestos and Mesothelioma News - September 19, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Cells Slowed by Grape-Seed Extracts
Extracts from two Italian grape varieties showed distinct anti-cancer activity in three different mesothelioma cell lines, according to a recent multicenter study in Naples, Italy. The in-vitro findings strongly suggest potential of a novel, nonconventional mesothelioma treatment advancement in the future for this aggressive, difficult-to-treat cancer. Previous laboratory studies have shown a negative impact of grape-seed extracts on breast, colon and skin cancer cells, but this was the first using multiple human mesothelioma cell lines. “Our study on mesothelioma seems very promising, but it is a preliminary analysi...
Source: Asbestos and Mesothelioma News - September 12, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Asbestos in Makeup Leads to Recall of City Color Products
Beauty Plus Global Inc., the cosmetics and packaging manufacturer behind City Color and Max Mell, has issued a voluntary recall of four City Color makeup products that tested positive for asbestos contamination. The U.S. Food and Drug Administration announced the recall Friday in the agency’s latest advisory regarding asbestos-contaminated cosmetics. The four recalled City Color products include: Beauty Plus Global Inc. City Color Collection Matte Blush (Fuchsia) — SKU #849136008807, Lot No. 1605020/PD-840 Beauty Plus Global Inc. City Color Cosmetics Timeless Beauty Palette — SKU #849136012958,...
Source: Asbestos and Mesothelioma News - September 9, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Clinical Trial Targets Latest Gene Therapy
Pioneering pulmonologists Dr. Steven Albelda and Dr. Daniel Sterman have worked for more than 20 years on developing gene therapy to effectively combat pleural mesothelioma cancer. The payoff may have finally arrived. Albelda and Sterman’s long-awaited, phase III clinical trial will open this month to evaluate the efficacy of TR002, a novel gene therapy drug, when used in combination with celecoxib and gemcitabine. TR002, a form of immunotherapy, is a genetically engineered adenovirus that triggers the anti-tumor effects of interferon, a naturally occurring protein that destroys cancer cells. “The hope is, if i...
Source: Asbestos and Mesothelioma News - September 4, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news

St. Louis auto mechanic wins $8M verdict for asbestos exposure
A St. Louis auto mechanic won $8.4 million against Ford Motor Co. for asbestos exposure in the 1960s, ‘70s and ‘80s while working at its dealerships. The mechanic, Al Bennett, and his wife, Pam Bennett, were represented by Chris Layloff and Jason Steinmeyer of the Gori Law Firm, who argued that he was exposed to asbestos through regular contact with brakes, gaskets, clutches and replacement par ts, leading to pleural mesothelioma diagnosis in his right lung. Now retired, Bennett continues to… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 30, 2019 Category: Biotechnology Authors: Greg Edwards Source Type: news

St. Louis auto mechanic wins $8M verdict for asbestos exposure
A St. Louis auto mechanic won $8.4 million against Ford Motor Co. for asbestos exposure in the 1960s, ‘70s and ‘80s while working at its dealerships. The mechanic, Al Bennett, and his wife, Pam Bennett, were represented by Chris Layloff and Jason Steinmeyer of the Gori Law Firm, who argued that he was exposed to asbestos through regular contact with brakes, gaskets, clutches and replacement par ts, leading to pleural mesothelioma diagnosis in his right lung. Now retired, Bennett continues to… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 30, 2019 Category: Pharmaceuticals Authors: Greg Edwards Source Type: news

MD Anderson Remains Top-Ranked Cancer Center
U.S. News & World Report named University of Texas MD Anderson Cancer Center in Houston as the No. 1 Adult Cancer Hospital in America for the fifth consecutive year. Memorial Sloan-Kettering Cancer Center in New York, Mayo Clinic in Rochester, Minnesota, Johns Hopkins Hospital in Baltimore and Dana-Farber/Brigham and Women’s Cancer Center in Boston, round out the top five, respectively. All five have highly regarded specialty centers for pleural mesothelioma, the rare and aggressive cancer caused by the inhalation of asbestos fibers. The expertise in mesothelioma treatment contributed to the top rankings in the 2...
Source: Asbestos and Mesothelioma News - August 28, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news